Complementing the
current gold standard
for sepsis diagnosis
Finally a simple solution for a complex challenge
Sepsis is one of the deadliest medical emergencies, with mortality rates reaching up to 40%. Accurate, timely diagnosis is critical to saving lives. Yet blood culture contamination remains a persistent barrier, leading to false positives, delayed treatment, and increased healthcare costs. Existing devices on the market often rely on complex engineering and come with high costs, limiting their adoption and scalability.Based on a proven principle
Contamination in blood cultures often occur during the initial moments of blood draw, when skin-residing bacteria can enter the sample despite proper sterilization. The proven solution? Initial specimen diversion.
This principle involves diverting the first few drops of blood — those most likely to carry contaminants — before they enter the culture bottle. By removing these early drops, the sample that follows is significantly less likely to be compromised.
Our solution is built around this trusted method. By seamlessly integrating blood diversion into the current sampling process, it supports cleaner sample collection without adding complexity, hence reducing contamination risk and helping ensure more reliable diagnostic results. 
From health care professionals
for health care professionals
Our team has a deep understanding of both the diagnostic lab environment and the realities of frontline care.
This is why we know: every drop matters.
Unlike other systems that discard the diverted blood, our device collects it into a standard blood tube, making it available for non-microbiological testing. This means less waste, fewer additional draws, and more value from every sampling event.
Minimal disruption, maximum clinical benefit.
